The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000812392
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
15/06/2026
Date registered
Help: Date registered
7/07/2026
Date last updated
Help: Date last updated
7/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
7/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
How effective is digital blood pressure management program (Lyfy) in the Australia general practice setting?
Scientific title
Implementing a digital blood pressure management program (Lyfy) for adults with elevated blood pressure in Australian primary care: a pilot study
Additional trial identifiers [1] 317580 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Hypertension 342341 0
Condition category
Condition code
Cardiovascular 338469 338469 0 0
Hypertension

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The Lyfy hypertension management platform is an AI-enabled digital health intervention designed to support the management of blood pressure through systematic analysis of personal health data, generation of individualised care plans, and engagement with healthcare professionals. The platform interprets user-entered blood pressure measurement and other health metrics to identify relevant trends, produces tailored evidence-based lifestyle prescriptions (DASH-based diet & exercise prescription), and provides general practitioners with summarised progress data to inform clinical decision-making with patient’s consent. Its model incorporates multi-disciplinary input from accredited dieticians, physiotherapists, exercise physiologists, and lifestyle medicine trained general practitioners, and adjust recommendations as user data evolves.

All participants will have access to the intervention for 12 weeks and their engagement will be measured by Lyfy backstage in terms of frequency of login and completion rate of the lifestyle prescription. They will interact with the Lyfy platform via a smartphone app for 10 - 15 minutes a day on average to receive their lifestyle prescriptions including:
- Exercise prescription in FITT format: Frequency, Intensity, Type, Time (duration) with short demonstration videos for certain exercise types. The exercise type ranged from cardio such as brisk walking/jogging/cycling to resistance training of chest, back, upper & lower limbs as well as isometric exercise such as plank & wall squat.
- DASH (Dietary Approach to Stop Hypertension) diet-based meal recommendation as an interactive interface for visualisation and calculation of macronutrients.
- Sleep hygiene tips sent as short messages via the Lyfy app.
They will also receive notifications via the app to monitor their blood pressure on regular basis and log the measurement to the app. The Lyfy algorithm will provide them with clinical insight based on the individual blood pressure readings as well as their overall trend.

The clinicians will be given access to the Lyfy clinician portal as a web page. They will be able to monitor the progress of their participating patients and check the completion rate of suggested lifestyle modifications. They also have the option to provide asynchronous feedback and adjust the lifestyle prescription accordingly. The average time spent by the clinicians on each participating patients would be approximately 5 minutes per fortnight. Each clinician would have an average of 10 participants. They can also log into the portal to visualise patients' input of blood pressure readings during the consultation to provide better informed clinical decisions.
Intervention code [1] 334386 0
Lifestyle
Intervention code [2] 334547 0
Treatment: Other
Description of the comparator or control
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 345762 0
Feasibility of the digital blood pressure management program
Timepoint [1] 345762 0
At the end of the 12 weeks intervention
Primary outcome [2] 345763 0
Acceptability of the digital blood pressure management program
Timepoint [2] 345763 0
At the end of the 12 weeks intervention
Secondary outcome [1] 463196 0
Systolic Blood pressure
Timepoint [1] 463196 0
Week 6 and week 12 of the intervention
Secondary outcome [2] 463197 0
Lifestyle behavioural changes including: - Nutrition - Physical activity - Sleep - Social connections - Stress & resilience - Time in the nature or outdoors - Screen time - Substance use - Positivity - Meaning & purpose All lifestyle behavioural changes will be assessed as a composite secondary outcome
Timepoint [2] 463197 0
Week 12 of the intervention
Secondary outcome [3] 464517 0
Diastolic Blood Pressure
Timepoint [3] 464517 0
Week 6 and week 12 of the intervention

Eligibility
Key inclusion criteria
Participants will be eligible for inclusion if they meet the following criteria:
• Adults aged greater or equal to 18 years old, including both males and females.
• Elevated blood pressure within the target range, defined as a systolic blood pressure of 130–160 mmHg and/or a diastolic blood pressure of 80–100 mmHg, based on the mean of three seated measurements taken after a 5 minute rest period, either in the clinic or at home
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Participants will be excluded if they meet any of the following conditions:
• Secondary hypertension or elevated blood pressure attributable to a cause other than essential hypertension.
• Poorly controlled diabetes, defined as HbA1c > 8%.
• Recent cardiac event within the past 6 months (e.g., myocardial infarction, unstable angina, or heart failure exacerbation).

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Pilot study with convenient sampling of 50 participants from Lyfy platform as well as collaborating GP clinics.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 322138 0
University
Name [1] 322138 0
James Cook University - supervisors time to guide the research project
Country [1] 322138 0
Australia
Funding source category [2] 322267 0
Commercial sector/Industry
Name [2] 322267 0
Lyfy - Providing access to the platform and tech support
Country [2] 322267 0
Australia
Primary sponsor type
University
Name
James Cook University
Address
Country
Australia
Secondary sponsor category [1] 325030 0
None
Name [1] 325030 0
Address [1] 325030 0
Country [1] 325030 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320669 0
Bellberry Human Research Ethics Committee A
Ethics committee address [1] 320669 0
Ethics committee country [1] 320669 0
Australia
Date submitted for ethics approval [1] 320669 0
16/02/2026
Approval date [1] 320669 0
29/05/2026
Ethics approval number [1] 320669 0
2026-02-236

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151226 0
Dr Yuanchun (Frank) Wang
Address 151226 0
Building 39, James Cook Drive, James Cook University, Townsville, Queensland 4811, Australia
Country 151226 0
Australia
Phone 151226 0
+61 430850115
Fax 151226 0
Email 151226 0
Contact person for public queries
Name 151227 0
Yuanchun (Frank) Wang
Address 151227 0
Building 39, James Cook Drive, James Cook University, Townsville, Queensland 4811, Australia
Country 151227 0
Australia
Phone 151227 0
+61 430850115
Fax 151227 0
Email 151227 0
Contact person for scientific queries
Name 151228 0
Yuanchun (Frank) Wang
Address 151228 0
Building 39, James Cook Drive, James Cook University, Townsville, Queensland 4811, Australia
Country 151228 0
Australia
Phone 151228 0
+61 430850115
Fax 151228 0
Email 151228 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• De-identified individual participant data:
• Published results
What types of analyses could be done with individual participant data?
• Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: Jame Cook University - [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.